A

Atossa Therapeutics
D

ATOS

0.79610
USD
-0.04
(-5.21%)
مغلق
حجم التداول
2,132
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
100,150,378
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARCT
    0.846
    (5.00%)
    17.770 USD
    B
    BNGO
    0.01500
    (0.28%)
    5.36500 USD
    C
    CODX
    0.01720
    (2.46%)
    0.71700 USD
    I
    IDT
    -0.890
    (-1.80%)
    48.610 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    T
    TNXP
    -0.53000
    (-5.48%)
    9.15000 USD
    V
    VXRT
    0.00670
    (0.95%)
    0.70980 USD
    المزيد
الأخبار
المقالات

العنوان: Atossa Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.